Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives

References

• Bruera ED, Portenoy RK, eds, Cancer Pain: Assessment and Management. New York (NY): Cambridge University Press; 2003:413–428.
   Google Scholar
• Smith HS. Painful osseous metastases. Pain Physician. 2011;14(4):E373–403.21785487
   PubMed Web of Science ®Google Scholar
• Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2(8):584–593. doi:10.1038/nrc86712154351
   PubMed Web of Science ®Google Scholar
• Weinfurt KP, Li Y, Castel LD, et al. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer. Ann Oncol. 2005;16(4):579–584. doi:10.1093/annonc/mdi12215734776
   PubMed Web of Science ®Google Scholar
• Decroisette C, Monnet I, Berard H, et al. Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicentre study (GFPC 0601). J Thorac Oncol. 2011;6(3):576–582. doi:10.1097/JTO.0b013e318206a1e321270669
   PubMed Web of Science ®Google Scholar
• Lutz S, Balboni T, Jones J, et al. Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol. 2017;7(1):4–12. doi:10.1016/j.prro.2016.08.00127663933
   PubMed Web of Science ®Google Scholar
• Rich SE, Chow R, Raman S, et al. Update of the systematic review of palliative radiation therapy fractionation for bone metastases. Radiother Oncol. 2018;126(3):547–557. doi:10.1016/j.radonc.2018.01.00329397209
   PubMed Web of Science ®Google Scholar
• Huisman M, van Den Bosch MA, Wijlemans JW, et al. Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2012;84(1):8–14. doi:10.1016/j.ijrobp.2011.10.08022300568
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.v69.130620402
   PubMed Web of Science ®Google Scholar
• Barzilai O, Versteeg AL, Sahgal A, et al. Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: a multicenter, international study. Cancer. 2019;125(5):770–778. doi:10.1002/cncr.3187030489634
   PubMed Web of Science ®Google Scholar
• Sprave T, Verma V, Förster R, et al. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy. Radiother Oncol. 2018;128(2):274–282. doi:10.1016/j.radonc.2018.04.03029843899
   PubMed Web of Science ®Google Scholar
• van der Velden JM, Verkooijen HM, Seravalli E, et al. Comparing conVEntional radiotherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design. BMC Cancer. 2016;16(1):909. doi:10.1186/s12885-016-2947-027871280
   PubMedGoogle Scholar
• Ryu S, Pugh SL, Gerszten PC, et al. RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. Pract Radiat Oncol. 2014;4(2):76–81. doi:10.1016/j.prro.2013.05.00124890347
   PubMedGoogle Scholar
• Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2,open-label trial. Lancet. 2019;393(10185):2051–2058. doi:10.1016/S0140-6736(18)32487-530982687
   PubMed Web of Science ®Google Scholar
• Katsoulakis E, Laufer I, Bilsky M, et al. Pathological characteristics of spine metastases treated with high-dose single-fraction stereotactic radiosurgery. Neurosurg Focus. 2017;42(1):E7. doi:10.3171/2016.10.FOCUS16368
   PubMed Web of Science ®Google Scholar
• van Den Hout WB, van der Linden YM, Steenland E. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst. 2003;95(3):222–229. doi:10.1093/jnci/95.3.22212569144
   PubMedGoogle Scholar
• Klimo P Jr, Schmidt MH. Surgical management of spinal metastases. Oncologist. 2004;9(2):188–196. doi:10.1634/theoncologist.9-2-18815047923
   PubMed Web of Science ®Google Scholar
• Hamilton AJ, Lulu BA, Fosmire H, Stea B, Cassady JR. Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery. 1995;36(2):311–319. doi:10.1227/00006123-199502000-00107731511
   PubMed Web of Science ®Google Scholar
• Ryu S, Fang Yin F, Rock J, et al. Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer. 2003;97(8):2013–2018. doi:10.1002/cncr.1129612673732
   PubMed Web of Science ®Google Scholar
• Garg AK, Shiu AS, Yang J, et al. Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer. 2012;118(20):5069–5077. doi:10.1002/cncr.2753022511344
   PubMed Web of Science ®Google Scholar
• Ryu S, Rock J, Rosenblum M, Kim JH. Patterns of failure after single-dose radiosurgery for spinal metastasis. J Neurosurg. 2004;101(S3):402–405. doi:10.3171/sup.2004.101.supplement3.0402
   PubMedGoogle Scholar
• Leeman JE, Bilsky M, Laufer I, et al. Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study. J Neurosurg Spine. 2016;25(1):52–58. doi:10.3171/2015.11.SPINE15105926943256
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Burton SA, Ozhasoglu C, Welch WC. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976). 2007;32(2):193–199. doi:10.1097/01.brs.000251863.76595.a217224814
   PubMed Web of Science ®Google Scholar
• Bishop AJ, Tao R, Guadagnolo BA, et al. Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations. J Neurosurg Spine. 2017;27(3):303–311. doi:10.3171/2017.1.SPINE16104528644075
   PubMed Web of Science ®Google Scholar
• Yamada Y, Katsoulakis E, Laufer I, et al. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery. Neurosurg Focus. 2017;42(1):E6. doi:10.3171/2016.9.FOCUS16369
   PubMed Web of Science ®Google Scholar
• Jahaveri PM, Teh BS, Paulino AC, et al. A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases. Acta Oncol. 2012;51(5):584–588. doi:10.3109/0284186X.2011.65274122248089
   PubMed Web of Science ®Google Scholar
• Rose PS, Laufer I, Boland PJ, et al. Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol. 2009;27(30):5075–5079. doi:10.1200/JCO.2008.19.350819738130
   PubMed Web of Science ®Google Scholar
• Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003;300(5622):1155–1159. doi:10.1126/science.108250412750523
   PubMed Web of Science ®Google Scholar
• Steverink JG, Willems SM, Philippens MEP, et al. Early tissue effects of stereotactic body radiation therapy for spinal metastases. Int J Radiat Oncol Biol Phys. 2018;100(5):1254–1258. doi:10.1016/j.ijrobp.2018.01.00529439885
   PubMed Web of Science ®Google Scholar
• Heron DE, Rajagopalan MS, Stone B, et al. Single-session and multisession CyberKnife radiosurgery for spine metastases-University of Pittsburgh and Georgetown University experience. J Neurosurg Spine. 2012;17(1):11–18. doi:10.3171/2012.4.SPINE11902
   PubMed Web of Science ®Google Scholar
• Ghia AJ, Chang EL, Bishop AJ, et al. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials. J Neurosurg Spine. 2016;24(5):829–836. doi:10.3171/2015.8.SPINE1584426799117
   PubMed Web of Science ®Google Scholar
• Folkert MR, Bilsky MH, Tom AK, et al. Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine. Int J Radiat Oncol Biol Phys. 2014;88(5):1085–1091. doi:10.1016/j.ijrobp.2013.12.04224661662
   PubMed Web of Science ®Google Scholar
• Ning MS, Deegan BJ, Ho JC, et al. Low incidence of late failure and toxicity after spine stereotactic radiosurgery: secondary analysis of phase I/II trials with long-term follow-up. Radiother Oncol. 2019;138:80–85. doi:10.1016/j.radonc.2019.06.00331252298
   PubMed Web of Science ®Google Scholar
• Yoo GS, Park HC, Yu JI, et al. Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture. Oncotarget. 2017;8(42):72860–72871. doi:10.18632/oncotarget.v8i4229069831
   PubMedGoogle Scholar
• Ling DC, Flickinger JC, Burton SA, et al. Long-term outcomes after stereotactic radiosurgery for spine metastases: radiation dose-response for late toxicity. Int J Radiat Oncol Biol Phys. 2018;101(3):602–609. doi:10.1016/j.ijrobp.2018.02.03529678526
   PubMed Web of Science ®Google Scholar
• Sahgal A, Atenafu EG, Chao S, et al. Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol. 2013;31(27):3426–3431. doi:10.1200/JCO.2013.50.141123960179
   PubMed Web of Science ®Google Scholar
• Napieralska A, Miszczyk L, Stapor-Fudzinska M. CyberKnife stereotactic radiosurgery and stereotactic ablative radiation therapy of patients with prostate cancer bone metastases. Neoplasma. 2016;63(2):304–312. doi:10.4149/218_150807N43526774153
   PubMed Web of Science ®Google Scholar
• Boyce-Fappiano D, Elibe E, Schultz L, et al. Analysis of the factors contributing to vertebral compression fractures after spine stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2017;97(2):236–245. doi:10.1016/j.ijrobp.2016.09.00728068232
   PubMed Web of Science ®Google Scholar
• Thibault I, Whyne CM, Zhou S, et al. Volume of lytic vertebral body metastatic disease quantified using computed tomography-based image segmentation predicts fracture risk after spine stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2017;97(1):75–81. doi:10.1016/j.ijrobp.2016.09.02927843032
   PubMed Web of Science ®Google Scholar
• Tseng CL, Soliman H, Myrehaug S, et al. Imaging-based outcomes for 24 Gy in 2 daily fractions for patients with de novo spinal metastases treated with spine stereotactic body radiation therapy (SBRT). Int J Radiat Oncol Biol Phys. 2018;102(3):499–507. doi:10.1016/j.ijrobp.2018.06.04730003994
   PubMedGoogle Scholar
• Jawad MS, Fahim DK, Gerszten PC, et al. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation. J Neurosurg Spine. 2016;24(6):928–936. doi:10.3171/2015.10.SPINE14126126895526
   PubMed Web of Science ®Google Scholar
• Thibault I, Al-Omair A, Masucci GL, et al. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture. J Neurosurg Spine. 2014;21(5):711–718. doi:10.3171/2014.7.SPINE1389525170656
   PubMed Web of Science ®Google Scholar
• Boehling NS, Grosshans DR, Allen PK, et al. Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases. J Neurosurg Spine. 2012;16(4):379–386. doi:10.3171/2011.11.SPINE11622225488
   PubMed Web of Science ®Google Scholar
• Kelley KD, Racareanu R, Sison CP, et al. Outcomes in the radiosurgical management of metastatic spine disease. Adv Radiat Oncol. 2018;4(2):283–293. doi:10.1016/j.adro.2018.10.00731011673
   PubMedGoogle Scholar
• Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976). 2010;35(22):E1221–9. doi:10.1097/BRS.0b013e3181e16ae220562730
   PubMed Web of Science ®Google Scholar
• Lee SH, Tatsui CE, Ghia AJ, et al. Can the spinal instability neoplastic score prior to spinal radiosurgery predict compression fractures following stereotactic spinal radiosurgery for metastatic spinal tumor?: a post hoc analysis of prospective phase II single-institution trials. J Neurooncol. 2016;126(3):509–517. doi:10.1007/s11060-015-1990-z26643804
   PubMed Web of Science ®Google Scholar
• Kassamali RH, Ganeshan A, Hoey ET, Crowe PM, Douis H, Henderson J. Pain management in spinal metastases: the role of percutaneous vertebral augmentation. Ann Oncol. 2011;22(4):782–786. doi:10.1093/annonc/mdq60520966180
   PubMed Web of Science ®Google Scholar
• Wardak Z, Bland R, Ahn C, et al. A phase 2 clinical trial of SABR followed by immediate vertebroplasty for spine metastases. Int J Radiat Oncol Biol Phys. 2019;104(1):83–89. doi:10.1016/j.ijrobp.2019.01.07230684664
   PubMed Web of Science ®Google Scholar
• Ozdemir Y, Torun N, Guler OC, et al. Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases. J Bone Oncol. 2019;15:100218. doi:10.1016/j.jbo.2019.10021830815342
   PubMed Web of Science ®Google Scholar
• Pichon B, Campion L, Delpon G, et al. High-dose hypofractionated radiation therapy for noncompressive vertebral metastases in combination with zoledronate: a phase 1 study. Int J Radiat Oncol Biol Phys. 2016;96(4):840–847. doi:10.1016/j.ijrobp.2016.07.02727663759
   PubMed Web of Science ®Google Scholar
• Ito K, Ogawa H, Shimizuguchi T, et al. Stereotactic body radiotherapy for spinal metastases: clinical experience in 134 cases from a single Japanese institution. Technol Cancer Res Treat. 2018;17:1533033818806472. doi:10.1177/153303381880647230355246
   PubMed Web of Science ®Google Scholar
• Chang JH, Gandhidasan S, Finnigan R, et al. Stereotactic ablative body radiotherapy for the treatment of spinal oligometastases. Clin Oncol (R Coll Radiol). 2017;29(7):e119–e125. doi:10.1016/j.clon.2017.02.00428237218
   PubMed Web of Science ®Google Scholar
• Guckenberger M, Mantel F, Gerszten PC, et al. Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis. Radiat Oncol. 2014;9:226. doi:10.1186/s13014-014-0226-225319530
   PubMed Web of Science ®Google Scholar
• Nuyttens JJ, Moiseenko V, McLaughlin M, Jain S, Herbert S, Grimm J. Esophageal dose tolerance in patients treated with stereotactic body radiation therapy. Semin Radiat Oncol. 2016;26(2):120–128. doi:10.1016/j.semradonc.2015.11.00627000508
   PubMed Web of Science ®Google Scholar
• Abelson JA, Murphy JD, Loo BW Jr, et al. Esophageal tolerance to high-dose stereotactic ablative radiotherapy. Dis Esophagus. 2012;25(7):623–629. doi:10.1111/dote.2012.25.issue-722168251
   PubMed Web of Science ®Google Scholar
• Cox BW, Jackson A, Hunt M, Bilsky M, Yamada Y. Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012;83(5):e661–7. doi:10.1016/j.ijrobp.2012.01.08022572079
   PubMed Web of Science ®Google Scholar
• Onimaru R, Shirato H, Shimizu S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys. 2003;56(1):126–135. doi:10.1016/S0360-3016(03)00095-612694831
   PubMed Web of Science ®Google Scholar
• Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8–10. doi:10.1200/JCO.1995.13.1.87799047
   PubMed Web of Science ®Google Scholar
• Salama JK, Hasselle MD, Chmura SJ, et al. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer. 2012;118(11):2962–2970. doi:10.1002/cncr.2661122020702
   PubMed Web of Science ®Google Scholar
• Ho JC, Tang C, Deegan BJ, et al. The use of spine stereotactic radiosurgery for oligometastatic disease. J Neurosurg Spine. 2016;25(2):239–247. doi:10.3171/2016.1.SPINE15116627035507
   PubMed Web of Science ®Google Scholar
• Silva SR, Gliniewicz A, Martin B, et al. Oligometastatic disease state is associated with improved local control in patients undergoing three or five fraction spine stereotactic body radiotherapy. World Neurosurg. 2019;122:e342–e348. doi:10.1016/j.wneu.2018.10.04430326310
   PubMed Web of Science ®Google Scholar
• Loi M, Desideri I, Greto D, et al. Radiotherapy in the age of cancer immunology: current concepts and future developments. Crit Rev Oncol Hematol. 2017;112:1–10. doi:10.1016/j.critrevonc.2017.02.00228325250
   PubMed Web of Science ®Google Scholar
• Laufer I, Rubin DG, Lis E, et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist. 2013;18(6):744–751. doi:10.1634/theoncologist.2012-029323709750
   PubMed Web of Science ®Google Scholar
• Tang C, Hess K, Bishop AJ, et al. Creation of a prognostic index for spine metastasis to stratify survival in patients treated with spinal stereotactic radiosurgery: secondary analysis of mature prospective trials. Int J Radiat Oncol Biol Phys. 2015;93(1):118–125. doi:10.1016/j.ijrobp.2015.04.05026130231
   PubMed Web of Science ®Google Scholar
• Spratt DE, Beeler WH, de Moraes FY, et al. An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report. Lancet Oncol. 2017;18(12):e720–e730. doi:10.1016/S1470-2045(17)30612-529208438
   PubMed Web of Science ®Google Scholar
• Cox BW, Spratt DE, Lovelock M, et al. International Spine Radiosurgery Consortium consensus guidelines fortarget volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012;83(5):e597–e605. doi:10.1016/j.ijrobp.2012.03.00922608954
   PubMed Web of Science ®Google Scholar
• Ito K, Shimizuguchi T, Nihei K, et al. Patterns of intraosseous recurrence after stereotactic body radiation therapy for coxal bone metastasis. Int J Radiat Oncol Biol Phys. 2018;100(1):159–161. doi:10.1016/j.ijrobp.2017.08.04529066121
   PubMed Web of Science ®Google Scholar
• Yu T, Choi CW, Kim KS. Treatment outcomes of stereotactic ablative radiation therapy for non-spinal bone metastases: focus on response assessment and treatment indication. Br J Radiol. 2019;92(1099):20181048. doi:10.1259/bjr.2018104831075040
   PubMed Web of Science ®Google Scholar
• Erler D, Brotherston D, Sahgal A, et al. Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases. Radiother Oncol. 2018;127(2):304–309. doi:10.1016/j.radonc.2018.03.03029706460
   PubMed Web of Science ®Google Scholar
• Owen D, Laack NN, Mayo CS. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Pract Radiat Oncol. 2014;4(2):e143–e149. doi:10.1016/j.prro.2013.05.00624890360
   PubMedGoogle Scholar
• van der Linden YM, Steenland E, van Houwelingen HC, et al. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: results on survival in the Dutch Bone Metastasis Study. Radiother Oncol. 2006;78(3):245–253. doi:10.1016/j.radonc.2006.02.00716545474
   PubMed Web of Science ®Google Scholar
• Gaze MN, Kelly CG, Kerr GR, et al. Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol. 1997;45(2):109–116. doi:10.1016/S0167-8140(97)00101-19423999
   PubMed Web of Science ®Google Scholar
• Nguyen QN, Chun SG, Chow E, et al. Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases: a randomized phase 2 trial. JAMA Oncol. 2019;5:872. doi:10.1001/jamaoncol.2019.019231021390
   PubMed Web of Science ®Google Scholar
• Loi M, Klass ND, De Vries KC, et al. Pain flare, complexity and analgesia in bone oligometastases treated with stereotactic body radiation therapy. Eur J Cancer Care (Engl). 2018;27(6):e12915. doi:10.1111/ecc.1291530246916
   PubMed Web of Science ®Google Scholar
• Chiang A, Zeng L, Zhang L, et al. Pain flare is a common adverse event in steroid-naïve patients after spine stereotactic body radiation therapy: a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2013;86(4):638–642. doi:10.1016/j.ijrobp.2013.03.02223664326
   PubMed Web of Science ®Google Scholar
• Pan HY, Allen PK, Wang XS, et al. Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1/2 trials. Int J Radiat Oncol Biol Phys. 2014;90(4):870–876. doi:10.1016/j.ijrobp.2014.07.03725227497
   PubMed Web of Science ®Google Scholar
• Khan L, Chiang A, Zhang L, et al. Prophylactic dexamethasone effectively reduces the incidence of pain flare following spine stereotactic body radiotherapy (SBRT): a prospective observational study. Support Care Cancer. 2015;23(10):2937–2943. doi:10.1007/s00520-015-2659-z25752882
   PubMed Web of Science ®Google Scholar
• McGee HM, Carpenter TJ, Ozbek U, et al. Analysis of local control and pain control after spine stereotactic radiosurgery reveals inferior outcomes for hepatocellular carcinoma compared with other radioresistant histologies. Pract Radiat Oncol. 2019;9(2):89–97. doi:10.1016/j.prro.2018.11.00930543868
   PubMed Web of Science ®Google Scholar
• Mehta N, Zavitsanos PJ, Moldovan K, et al. Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases. Adv Radiat Oncol. 2018;3(3):245–251. doi:10.1016/j.adro.2018.04.00230202794
   PubMedGoogle Scholar
• Zeng KL, Myrehaug S, Soliman H, et al. Stereotactic body radiotherapy for spinal metastases at the extreme ends of the spine: imaging-based outcomes for cervical and sacral metastases. Neurosurgery. 2018. doi:10.1093/neuros/nyy393
   Google Scholar
• Fanetti G, Marvaso G, Ciardo D, et al. Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases. Med Oncol. 2018;35(5):75. doi:10.1007/s12032-018-1137-029671075
   PubMed Web of Science ®Google Scholar
• Guckenberger M, Sweeney RA, Hawkins M, et al. Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: results of a phase 2 study. Cancer. 2018;124(9):2001–2009. doi:10.1002/cncr.v124.929499073
   PubMed Web of Science ®Google Scholar
• Bernard V, Bishop AJ, Allen PK, et al. Heterogeneity in treatment response of spine metastases to spine stereotactic radiosurgery within “radiosensitive” subtypes. Int J Radiat Oncol Biol Phys. 2017;99(5):1207–1215. doi:10.1016/j.ijrobp.2017.08.02829029886
   PubMed Web of Science ®Google Scholar
• Bernstein MB, Chang EL, Amini B, et al. Spine stereotactic radiosurgery for patients with metastatic thyroid cancer: secondary analysis of phase I/II trials. Thyroid. 2016;26(9):1269–1275. doi:10.1089/thy.2016.004627334245
   PubMed Web of Science ®Google Scholar
• Germano IM, Carai A, Pawha P, et al. Clinical outcome of vertebral compression fracture after single fraction spine radiosurgery for spinal metastases. Clin Exp Metastasis. 2016;33(2):143–149. doi:10.1007/s10585-015-9764-826578533
   PubMed Web of Science ®Google Scholar
• Lee E, Kim TG, Park HC, et al. Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma. Radiat Oncol J. 2015;33(3):217–225. doi:10.3857/roj.2015.33.3.21726484305
   PubMedGoogle Scholar
• Amini A, Altoos B, Bourlon MT, et al. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: is RCC truly radioresistant? Pract Radiat Oncol. 2015;5(6):e589–e596. doi:10.1016/j.prro.2015.05.00426142027
   PubMedGoogle Scholar
• Bishop AJ, Tao R, Rebueno NC, et al. Outcomes for spine stereotactic body radiation therapy and an analysis of predictors of local recurrence. Int J Radiat Oncol Biol Phys. 2015;92(5):1016–1026. doi:10.1016/j.ijrobp.2015.03.03726025777
   PubMed Web of Science ®Google Scholar
• Anand AK, Venkadamanickam G, Punnakal AU, et al. Hypofractionated stereotactic body radiotherapy in spinal metastasis - withor without epidural extension. Clin Oncol (R Coll Radiol). 2015;27(6):345–352. doi:10.1016/j.clon.2015.01.03525726363
   PubMed Web of Science ®Google Scholar
• Balagamwala EH, Angelov L, Koyfman SA, et al. Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma. J Neurosurg Spine. 2012;17(6):556–564. doi:10.3171/2012.8.SPINE1230323020208
   PubMed Web of Science ®Google Scholar
• Ahmed KA, Stauder MC, Miller RC, et al. Stereotactic body radiation therapy in spinal metastases. Int J Radiat Oncol Biol Phys. 2012;82(5):e803–e809. doi:10.1016/j.ijrobp.2011.11.03622330988
   PubMed Web of Science ®Google Scholar
• Wang XS, Rhines LD, Shiu AS, et al. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol. 2012;13(4):395–402. doi:10.1016/S1470-2045(11)70384-922285199
   PubMed Web of Science ®Google Scholar
• Martin AG, Cowley IR, Taylor BA, et al. (Stereotactic) radiosurgery XIX: spinal radiosurgery–two year experience in a UK centre. Br J Neurosurg. 2012;26(1):53–58. doi:10.3109/02688697.2011.60385722026444
   PubMed Web of Science ®Google Scholar
• Muacevic A, Kufeld M, Rist C, Wowra B, Stief C, Staehler M. Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer. Urol Oncol. 2013;31(4):455–460. doi:10.1016/j.urolonc.2011.02.02321481619
   PubMed Web of Science ®Google Scholar
• Nguyen QN, Shiu AS, Rhines LD, et al. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2010;76(4):1185–1192. doi:10.1016/j.ijrobp.2009.03.06219632064
   PubMed Web of Science ®Google Scholar
• Amdur RJ, Bennett J, Olivier K, et al. A prospective, phase II study demonstrating the potential value and limitation of radiosurgery for spine metastases. Am J Clin Oncol. 2009;32(5):515–520. doi:10.1097/COC.0b013e318194f70f19528790
   PubMed Web of Science ®Google Scholar
• Tsai JT, Lin JW, Chiu WT, Chu WC. Assessment of image-guided CyberKnife radiosurgery for metastatic spine tumors. J Neurooncol. 2009;94(1):119–127. doi:10.1007/s11060-009-9814-719255725
   PubMed Web of Science ®Google Scholar
• Chang EL, Shiu AS, Mendel E, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. 2007;7(2):151–160. doi:10.3171/SPI-07/08/15117688054
   PubMed Web of Science ®Google Scholar
• Gibbs IC, Kamnerdsupaphon P, Ryu MR, et al. Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol. 2007;82(2):185–190. doi:10.1016/j.radonc.2006.11.02317257702
   PubMed Web of Science ®Google Scholar
• Sharma M, Bennett EE, Rahmathulla G, et al. Impact of cervicothoracic region stereotactic spine radiosurgery on adjacent organs at risk. Neurosurg Focus. 2017;42(1):E14. doi:10.3171/2016.10.FOCUS16364
   PubMed Web of Science ®Google Scholar
• Hashmi A, Guckenberger M, Kersh R, et al. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis. J Neurosurg Spine. 2016;25(5):646–653. doi:10.3171/2016.4.SPINE15152327341054
   PubMed Web of Science ®Google Scholar
• Moussazadeh N, Lis E, Katsoulakis E, et al. Five-year outcomes of high-dose single-fraction spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2015;93(2):361–367. doi:10.1016/j.ijrobp.2015.05.03526232858
   PubMed Web of Science ®Google Scholar